|
|
Volumn 272, Issue 5270, 1996, Pages 1880-1881
|
|
The marketplace of HIV/AID$
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIGEN P24;
ANTIVIRUS AGENT;
CD4 ANTIGEN;
DELAVIRDINE;
DIDANOSINE;
HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
LAMIVUDINE;
NEVIRAPINE;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
VIRUS ENVELOPE PROTEIN;
VIRUS RNA;
ZALCITABINE;
ZIDOVUDINE;
CLINICAL TRIAL;
DRUG COST;
DRUG DESIGN;
DRUG MARKETING;
DRUG MIXTURE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
HEALTH ECONOMICS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MEDICAL RESEARCH;
NOTE;
PRIORITY JOURNAL;
SCREENING TEST;
VACCINE PRODUCTION;
VIRUS ENVELOPE;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AIDS VACCINES;
ANTIVIRAL AGENTS;
HIV;
HIV PROTEASE INHIBITORS;
HUMANS;
INVESTMENTS;
REVERSE TRANSCRIPTASE INHIBITORS;
HUMAN IMMUNODEFICIENCY VIRUS;
|
|
EID: 0030037261
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.272.5270.1880 Document Type: Note |
|
Times cited : (10)
|
|
References (0)
|